Paul Nderitu

Dr. Paul Nderitu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2017 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
PNPaul Nderitu
Paul Nderitu
CBCecilia Bosco
Cecilia Bosco
HGHans Garmo
Hans Garmo
LHLars Holmberg
Lars Holmberg
HMHåkan Malmström
Håkan Malmström
MHMieke Van Hemelrijck
Mieke Van Hemelrijck
Metabolic syndrome (MetS) is associated with non‐alcoholic fatty liver disease, which may progress to cirrhosis, a significant risk factor of hepatocellular carcinoma (HCC), the commonest malignant primary liver cancer (PLC). We investigated the association between the individual components of MetS (lipids, apolipoproteins, raised glucose, diabetes and obesity), PLC and cirrhosis. A total of 509,436 participants from the Swedish AMORIS cohort, recruited between January 1985 and December 1996 (end‐date December 2011), aged ≥20 with baseline triglycerides (TG), total cholesterol (TC), glucose and liver enzymes were included. Those with baseline benign liver tumours, PLC or cirrhosis were excluded. Multivariate Cox regression, adjusted for age, gender, socio‐economic status, liver disease (excluding cirrhosis) and MetS factors were used to estimate the association with PLC and cirrhosis. There were 766 PLC and 2,775 cirrhosis cases over 13 years. Raised TG, low TC, raised glucose, diabetes and low HDL were associated with an increased risk of developing PLC and cirrhosis. ApoB/ApoA‐I ratio were also associated with PLC, whilst low LDL, raised TG/HDL, low ApoA‐I and low ApoB were associated with cirrhosis. Obesity was significantly associated with PLC but not cirrhosis. Raised TG, low TC, raised glucose and diabetes showed stronger associations with PLC in participants with cirrhosis but many participants developed PLC without cirrhosis. Individual components of MetS (lipids, apolipoproteins, raised glucose, diabetes and obesity) were associated with an increased risk of developing PLC or cirrhosis. MetS components were more strongly associated with PLC with preceding cirrhosis history but many participants developed PLC without cirrhosis.

1 February 2019 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
PNPaul Nderitu
Paul Nderitu
PUPaul Ursell
Paul Ursell
To compare iris hooks and a pupil expansion ring (Malyugin ring) in eyes with a small pupil. Epsom and St. Helier University National Health Service Trust, London, United Kingdom. Retrospective case series. Patients who had primary phacoemulsification cataract surgery from January 1, 2012, to December 30, 2016, were included. Combined procedures and surgeons with fewer than 50 cases were excluded. Anonymized data were demographics, surgeon grade, case complexity, iris hooks or Malyugin ring use, posterior capsule rupture, zonular fiber rupture or dialysis, vitreous loss, operating time, postoperative complications, and visual acuity. Of the 9552 cases included, 425 (4.4%) had a small pupil, 314 of which required a pupil expansion ring and 95 iris hooks. Compared with no pupil expander, iris hooks were associated with an additional operating time of 14 minutes for consultants and 24 minutes for trainees. The pupil expansion ring was associated with an additional operating time of 4 minutes and 6 minutes, respectively. Neither pupil expander was associated with more intraoperative complications. The pupil expansion ring was associated with higher postoperative anterior uveitis and corneal edema rates. Pupil expander cases achieved equivalent visual acuity gains. The pupil expansion ring and iris hooks were safe and effective in minimizing intraoperative complications in eyes with a small pupil. The pupil expansion ring was faster to use than iris hooks. Monitoring for signs of postoperative anterior uveitis or cornea edema with careful insertion or removal of pupil expansion rings is advocated.

20 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
UAUazman Alam
Uazman Alam
MAMatthew Anson
Matthew Anson
YMYanda Meng
Yanda Meng
FPFrank George Preston
Frank George Preston
VKVaro Kirthi
Varo Kirthi
IPIoannis N. Petropoulos
Ioannis N. Petropoulos
Corneal confocal microscopy (CCM) is a rapid non-invasive in vivo ophthalmic imaging technique that images the cornea. Historically, it was utilised in the diagnosis and clinical management of corneal epithelial and stromal disorders. However, over the past 20 years, CCM has been increasingly used to image sub-basal small nerve fibres in a variety of peripheral neuropathies and central neurodegenerative diseases. CCM has been used to identify subclinical nerve damage and to predict the development of diabetic peripheral neuropathy (DPN). The complex structure of the corneal sub-basal nerve plexus can be readily analysed through nerve segmentation with manual or automated quantification of parameters such as corneal nerve fibre length (CNFL), nerve fibre density (CNFD), and nerve branch density (CNBD). Large quantities of 2D corneal nerve images lend themselves to the application of artificial intelligence (AI)-based deep learning algorithms (DLA). Indeed, DLA have demonstrated performance comparable to manual but superior to automated quantification of corneal nerve morphology. Recently, our end-to-end classification with a 3 class AI model demonstrated high sensitivity and specificity in differentiating healthy volunteers from people with and without peripheral neuropathy. We believe there is significant scope and need to apply AI to help differentiate between peripheral neuropathies and also central neurodegenerative disorders. AI has significant potential to enhance the diagnostic and prognostic utility of CCM in the management of both peripheral and central neurodegenerative diseases.

1 June 2019 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
PNPaul Nderitu
Paul Nderitu
PUPaul Ursell
Paul Ursell
To define factors affecting cataract surgery operating time for operating room planning, optimizing throughput, enhancing patient experiences, minimizing costs, and allocating training time. Epsom and St. Helier University National Health Service Trust, London, United Kingdom. Retrospective case series. All patients who had primary manual phacoemulsification cataract surgery from January 1, 2012, to December 30, 2016, were included. Combined anterior and posterior segment procedures and surgeons with fewer than 50 cases were excluded. Anonymized data collected were demographics, anesthesia, operating time, surgeon grade, case complexity, pupil size, pupil expander or capsular tension ring (CTR) use, intraocular lens type, posterior capsule or zonular fiber rupture or dialysis, vitreous loss, and automated anterior vitrectomy. From 11 067 cases, 9552 (86.3%) had a recorded operating time. The mean ± SD operating times in minutes were as follows: consultants 19 ± 10, junior 30 ± 11, intermediate 27 ± 12, senior trainees 24 ± 10, and fellows 31 ± 11. Operating time was significantly shorter for topical than for sub-Tenon or general anesthesia, especially among trainees. Consultant operating time remained unchanged with increasing case complexity, except for high-complexity cases. Small pupils, pupil expander or CTR use, posterior capsule or zonular fiber rupture or dialysis with or without vitreous loss (mean 45 ± 23) were associated with increased operating times. Iris hooks were associated with greater increases in operating time than Malyugin rings (16 minutes versus 6 minutes; P < .001). There was a modest 3-minute decrease in operating time among consultants over 5 years. Cataract surgery operating time was significantly influenced by anesthesia type, surgeon grade, high case complexity, pupil size, pupil expander use/type, CTR use, and intraoperative complications.

26 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JRJoan Nunez do Rio
Joan Nunez do Rio
PNPaul Nderitu
Paul Nderitu
CBChristos Bergeles
Christos Bergeles
SSSobha Sivaprasad
Sobha Sivaprasad
GTGavin S. W. Tan
Gavin S. W. Tan
Rajiv RamanRajiv Raman
Rajiv Raman
Artificial Intelligence has showcased clear capabilities to automatically grade diabetic retinopathy (DR) on mydriatic retinal images captured by clinical experts on fixed table-top retinal cameras within hospital settings. However, in many low- and middle-income countries, screening for DR revolves around minimally trained field workers using handheld non-mydriatic cameras in community settings. This prospective study evaluated the diagnostic accuracy of a deep learning algorithm developed using mydriatic retinal images by the Singapore Eye Research Institute, commercially available as Zeiss VISUHEALTH-AI DR, on images captured by field workers on a Zeiss Visuscout® 100 non-mydriatic handheld camera from people with diabetes in a house-to-house cross-sectional study across 20 regions in India. A total of 20,489 patient eyes from 11,199 patients were used to evaluate algorithm performance in identifying referable DR, non-referable DR, and gradability. For each category, the algorithm achieved precision values of 29.60 (95% CI 27.40, 31.88), 92.56 (92.13, 92.97), and 58.58 (56.97, 60.19), recall values of 62.69 (59.17, 66.12), 85.65 (85.11, 86.18), and 65.06 (63.40, 66.69), and F-score values of 40.22 (38.25, 42.21), 88.97 (88.62, 89.31), and 61.65 (60.50, 62.80), respectively. Model performance reached 91.22 (90.79, 91.64) sensitivity and 65.06 (63.40, 66.69) specificity at detecting gradability and 72.08 (70.68, 73.46) sensitivity and 85.65 (85.11, 86.18) specificity for the detection of all referable eyes. Algorithm accuracy is dependent on the quality of acquired retinal images, and this is a major limiting step for its global implementation in community non-mydriatic DR screening using handheld cameras. This study highlights the need to develop and train deep learning-based screening tools in such conditions before implementation.

12 July 2016 in BMJ Open
Verified
Journal Article
Open access
PDF file
PNPaul Nderitu
Paul Nderitu
Mieke Van HemelrijckMieke Van Hemelrijck
Mieke Van Hemelrijck
MAMark Ashworth
Mark Ashworth
RMRohini Mathur
Rohini Mathur
SHSally Hull
Sally Hull
SCSimon Chowdhury
Simon Chowdhury
Objectives To investigate the association between factors influencing prostate-specific antigen (PSA) testing prevalence including prostate cancer risk factors (age, ethnicity, obesity) and non-risk factors (social deprivation and comorbidity). Setting A cross-sectional database of 136 inner London general practices from 1 August 2009 to 31 July 2014. Participants Men aged ≥40 years without prostate cancer were included (n=150 481). Primary outcome Logistic regression analyses were used to estimate the association between PSA testing and age, ethnicity, social deprivation, body mass index (BMI) and comorbidity while adjusting for age, benign prostatic hypertrophy, prostatitis and tamsulosin or finasteride use. Results PSA testing prevalence was 8.2% (2013–2014), and the mean age was 54 years (SD 11). PSA testing was positively associated with age (OR 70–74 years compared to 40–44 years: 7.34 (95% CI 6.82 to 7.90)), ethnicity (black) (OR compared to white: 1.78 (95% CI 1.71 to 1.85)), increasing BMI and cardiovascular comorbidity. Testing was negatively associated with Chinese ethnicity and with increasing social deprivation. Conclusions PSA testing among black patients was higher compared to that among white patients, which differs from lower testing rates seen in previous studies. PSA testing was positively associated with prostate cancer risk factors and non-risk factors. Association with non-risk factors may increase the risk of unnecessary invasive diagnostic procedures.